BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24999633)

  • 21. Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan.
    Lin CH; Hsu KH; Chang SN; Tsou HK; Sheehan J; Sheu ML; Pan HC
    Radiat Oncol; 2015 Jun; 10():127. PubMed ID: 26048754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients with oral cancer do not undergo surgery as primary treatment: A population-based study in Taiwan.
    Wang CP; Liao LJ; Chiang CJ; Hsu WL; Kang CJ; Wang CC; Chen PR; Chen TC; Huang WW; Chien CY
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 3):392-398. PubMed ID: 31280909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology and Survival Outcomes of Lung Cancer: A Population-Based Study.
    Lin HT; Liu FC; Wu CY; Kuo CF; Lan WC; Yu HP
    Biomed Res Int; 2019; 2019():8148156. PubMed ID: 31976327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
    Yao ZH; Liao WY; Ho CC; Chen KY; Shih JY; Chen JS; Lin ZZ; Lin CC; Chih-Hsin Yang J; Yu CJ
    Oncologist; 2017 Sep; 22(9):1075-1083. PubMed ID: 28507206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlates of Refusal of Surgery in the Treatment of Non-metastatic Pancreatic Adenocarcinoma.
    Coffman A; Torgeson A; Lloyd S
    Ann Surg Oncol; 2019 Jan; 26(1):98-108. PubMed ID: 30145650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing a medical records-based and a claims-based index for measuring comorbidity in patients with lung or colon cancer.
    Kehl KL; Lamont EB; McNeil BJ; Bozeman SR; Kelley MJ; Keating NL
    J Geriatr Oncol; 2015 May; 6(3):202-10. PubMed ID: 25662785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the time interval from diagnosis to treatment on survival for early-stage liver cancer.
    Tsai WC; Kung PT; Wang YH; Kuo WY; Li YH
    PLoS One; 2018; 13(6):e0199532. PubMed ID: 29933395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer.
    Birim O; Kappetein AP; Goorden T; van Klaveren RJ; Bogers AJ
    Ann Thorac Surg; 2005 Sep; 80(3):1021-6. PubMed ID: 16122477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leading Comorbidity associated with 30-day post-anesthetic mortality in geriatric surgical patients in Taiwan: a retrospective study from the health insurance data.
    Chu CL; Chiou HY; Chou WH; Chang PY; Huang YY; Yeh HM
    BMC Geriatr; 2017 Oct; 17(1):245. PubMed ID: 29065869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latent TB infection in newly diagnosed lung cancer patients - A multicenter prospective observational study.
    Fan WC; Ting WY; Lee MC; Huang SF; Chiu CH; Lai SL; Chen YM; Shih JF; Lin CH; Kao SJ; Wu MF; Tsao TC; Wu CH; Yang KY; Lee YC; Feng JY; Su WJ
    Lung Cancer; 2014 Sep; 85(3):472-8. PubMed ID: 25063540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Comorbidities on Survival in Gastric, Colorectal, and Lung Cancer Patients.
    Morishima T; Matsumoto Y; Koeda N; Shimada H; Maruhama T; Matsuki D; Nakata K; Ito Y; Tabuchi T; Miyashiro I
    J Epidemiol; 2019 Mar; 29(3):110-115. PubMed ID: 30012908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality of patients with type 2 diabetes in Taiwan: a 10-year nationwide follow-up study.
    Lin WH; Hsu CH; Chen HF; Liu CC; Li CY
    Diabetes Res Clin Pract; 2015 Jan; 107(1):178-86. PubMed ID: 25451891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of chronic kidney disease with mortality risk in patients with lung cancer: a nationwide Taiwan population-based cohort study.
    Wei YF; Chen JY; Lee HS; Wu JT; Hsu CK; Hsu YC
    BMJ Open; 2018 Jan; 8(1):e019661. PubMed ID: 29371286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung cancer and prognosis in taiwan: a population-based cancer registry.
    Wang BY; Huang JY; Cheng CY; Lin CH; Ko J; Liaw YP
    J Thorac Oncol; 2013 Sep; 8(9):1128-35. PubMed ID: 23945383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors Associated with Refusal or Discontinuation of Treatment in Patients with Bladder Cancer: A Cohort Population-Based Study in Taiwan.
    Chang NT; Chang YH; Huang YT; Chen SC
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33450864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing health expenditure inflation under a single-payer system: Taiwan's National Health Insurance.
    Yip WC; Lee YC; Tsai SL; Chen B
    Soc Sci Med; 2019 Jul; 233():272-280. PubMed ID: 29548564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics and survival of patients with gynecological cancers who refuse radiotherapy: a retrospective cohort study.
    Zhang S; He J; Liu J
    BMC Womens Health; 2023 Nov; 23(1):562. PubMed ID: 37915037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial impact of multidisciplinary team management on the survival in different stages of oral cavity cancer patients: results of a nationwide cohort study in Taiwan.
    Tsai WC; Kung PT; Wang ST; Huang KH; Liu SA
    Oral Oncol; 2015 Feb; 51(2):105-11. PubMed ID: 25484134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of early use of Chinese herbal products on mortality rate in patients with lung cancer.
    Shen HS; Wen SH
    J Ethnopharmacol; 2018 Jan; 211():1-8. PubMed ID: 28942131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An in-depth assessment of a diagnosis-based risk adjustment model based on national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group case-mix system in Taiwan.
    Chang HY; Weiner JP
    BMC Med; 2010 Jan; 8():7. PubMed ID: 20082689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.